The last earnings report on December 31 showed earnings per share of -79 cents, missing the estimate of -66 cents. P/B Ratio (5.051) is normal, around the industry mean (10.296). P/E Ratio (0.000) is within average values for comparable stocks, (116.129). RNA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.466). RNA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (200.000) is also within normal values, averaging (233.055). With 641.65K shares outstanding, the current market capitalization sits at 2.53B.